Poland· PL-100376417
Renoscint MAG3
A 99mtc-technetium-mertiatid product containing betiatidum, registered in Poland by Medi-Radiopharma Kft.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium-mertiatid is registered in 10 of 19 countries.
Countries holding a registration under ATC V09CA03 (99mtc-technetium-mertiatid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
99mtc-technetium-mertiatid · ATC V09CA03
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Betiatidum
- Manufacturer
- Medi-Radiopharma Kft.
- Country
- Poland (PL)
- ATC code
- V09CA03
- ATC class
- 99mTc-Technetium-Mertiatid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991362362
- gtin05999881630077
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
99mtc-technetium-mertiatid in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRENOSCINT MAG3Medi-Radiopharma Kft., Érd
- United KingdomRenoscan MAG3 1mg kit for radiopharmaceutical preparationGE Healthcare Ltd
- BelgiumTechnescan MAG3 1 mgCurium Belgium
- SpainMAG3 RADIOPHARMACY 1 MG EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA EFGMedi-Radiopharma Kft.
- SwedenTechneScan MAG3 1 mg Beredningssats för radioaktivt läkemedelCurium Netherlands B.V.
- United StatesKit for the Preparation of Technetium Tc99m MertiatideSun Pharmaceutical Industries, Inc.
- GermanyRenoscint Mag3Medi-Radiopharma Kft.
- IrelandTechneScan MAG3, powder for solution for injectionCurium Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Renoscint Mag3, Technescan Mag3
- Belgium · Technescan Mag3
- Czechia · Renoscint Mag3, Technescan Mag3
- Germany · Renoscint Mag3, Technescan Mag3
- Denmark · Renoscint Mag3, Technescan Mag3
- Spain · Mag3 Radiopharmacy, Mag3 Technescan
- Finland · Technescan Mag3
- France · Technescan Mag 3
- United Kingdom (Northern Ireland) · Renoscan Mag3, Technescan Mag3
- Greece · Technescan Mag3
- Hungary · Renoscint Mag3, Technescan Mag3
- Ireland · Technescan Mag3
- Italy · Medirenoscint, Technescan Mag3
- Malta · Renoscint Mag3
- Netherlands · Technescan Mag3
- Norway · Technescan Mag3
- Portugal · Technescan Mag3
- Sweden · Technescan Mag3
- Slovakia · Technescan Mag3
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/28e1ee58-366d-4b15-8a46-a8682a7147b2 GET /v1/drugs/28e1ee58-366d-4b15-8a46-a8682a7147b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zestaw do sporządzania preparatu radiofarmaceutycznego",
"source": "urpl",
"strength": "1 mg",
"packaging": "05909991362362 ¦ Lz ¦ Skasowane ¦ 126744\n6 fiol. 10 ml\n05999881630077 ¦ Lz ¦ 142350\n6 fiol. 10 ml",
"substance": "Betiatide 1 mg",
"common_name": "Betiatidum",
"pl_product_id": "100376417",
"pozwolenie_nr": "24615",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about 99mtc-technetium-mertiatid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.